-
Je něco špatně v tomto záznamu ?
Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study
P. Piler, J. Švancara, L. Kukla, H. Pikhart,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1979-06-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest)
od 1979-06-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 1979-06-01 do Před 6 měsíci
Psychology Database (ProQuest)
od 1979-06-01 do Před 6 měsíci
Public Health Database (ProQuest)
od 1979-06-01 do Před 6 měsíci
PubMed
29371328
DOI
10.1136/jech-2017-209960
Knihovny.cz E-zdroje
- MeSH
- bronchiální astma epidemiologie MeSH
- kojenec MeSH
- lidé MeSH
- longitudinální studie MeSH
- matky MeSH
- neopioidní analgetika škodlivé účinky terapeutické užití MeSH
- paracetamol škodlivé účinky terapeutické užití MeSH
- postnatální péče MeSH
- předškolní dítě MeSH
- prenatální péče MeSH
- respirační zvuky etiologie MeSH
- rizikové faktory MeSH
- těhotenství MeSH
- zpožděný efekt prenatální expozice epidemiologie MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin. METHODS: We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records. RESULTS: 60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95% CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin. CONCLUSIONS: The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035432
- 003
- CZ-PrNML
- 005
- 20191014105618.0
- 007
- ta
- 008
- 191007s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/jech-2017-209960 $2 doi
- 035 __
- $a (PubMed)29371328
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Piler, Pavel $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study / $c P. Piler, J. Švancara, L. Kukla, H. Pikhart,
- 520 9_
- $a BACKGROUND: Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin. METHODS: We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records. RESULTS: 60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95% CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin. CONCLUSIONS: The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.
- 650 _2
- $a paracetamol $x škodlivé účinky $x terapeutické užití $7 D000082
- 650 _2
- $a neopioidní analgetika $x škodlivé účinky $x terapeutické užití $7 D018712
- 650 _2
- $a bronchiální astma $x epidemiologie $7 D001249
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matky $7 D009035
- 650 _2
- $a postnatální péče $7 D011181
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a prenatální péče $7 D011295
- 650 _2
- $a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
- 650 _2
- $a respirační zvuky $x etiologie $7 D012135
- 650 _2
- $a rizikové faktory $7 D012307
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Švancara, Jan $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic. Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Kukla, Lubomír $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Pikhart, Hynek $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic. Department of Epidemiology and Public Health, University College London, London, UK.
- 773 0_
- $w MED00002661 $t Journal of epidemiology and community health $x 1470-2738 $g Roč. 72, č. 4 (2018), s. 349-355
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29371328 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191014110042 $b ABA008
- 999 __
- $a ok $b bmc $g 1452092 $s 1073982
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 72 $c 4 $d 349-355 $e 20180125 $i 1470-2738 $m Journal of epidemiology and community health $n J Epidemiol Community Health $x MED00002661
- LZP __
- $a Pubmed-20191007